ASKA Pharmaceutical Holdings Co (TSE:4886) EV-to-FCF: (As of Jul. 20, 2026)

ASKA Pharmaceutical Holdings Co  (TSE:4886) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

ASKA Pharmaceutical Holdings Co's PE Ratio (TTM) for today is calculated as:

ASKA Pharmaceutical Holdings Co's share price for today is 円2244.00.
ASKA Pharmaceutical Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円191.120.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

ASKA Pharmaceutical Holdings Co EV-to-FCF Related Terms

The historical data trend for ASKA Pharmaceutical Holdings Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASKA Pharmaceutical Holdings Co EV-to-FCF Chart

ASKA Pharmaceutical Holdings Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EV-to-FCF	Get a 7-Day Free Trial															-66.48	0.00	0.00	0.00	21.55

TSE:4886 vs ZTS, UTHR: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ASKA Pharmaceutical Holdings Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ASKA Pharmaceutical Holdings Co EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ASKA Pharmaceutical Holdings Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where ASKA Pharmaceutical Holdings Co's EV-to-FCF falls into.

ASKA Pharmaceutical Holdings Co EV-to-FCF Calculation

ASKA Pharmaceutical Holdings Co's EV-to-FCF for today is calculated as:

ASKA Pharmaceutical Holdings Co's current Enterprise Value is 円70,595 Mil.
ASKA Pharmaceutical Holdings Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASKA Pharmaceutical Holdings Co Business Description